"At Minnesota Oncology, we are dedicated to providing compassionate care for various types of cancer and blood disorders in 12 convenient Twin Cities metro locations as well as several satellite locations. Our mission is to combine the strength of hope with the power of science, one patient at a time."

During the past decade, Minnesota Oncology - Burnsville conducted 108 clinical trials. In the 10-year time frame, 108 clinical trials started and 3 clinical trials were completed, i.e. on average, 2.8% percent of trials that started reached the finish line to date. In the past 5 years, 69 clinical trials started and 2 clinical trials were completed. i.e. 2.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Minnesota Oncology - Burnsville" #1 sponsor was "National Cancer Institute (NCI)" with 50 trials, followed by "Alliance for Clinical Trials in Oncology" with 21 trials sponsored, "SWOG Cancer Research Network" with 14 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored and "NRG Oncology" with 11 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Minnesota Oncology - Burnsville" #1 collaborator was "National Cancer Institute (NCI)" with 56 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Minnesota Oncology - Burnsville" are "Stage IV Lung Cancer AJCC v8" (7 trials), "Invasive Breast Carcinoma" (6 trials), "Stage IIIB Lung Cancer AJCC v8" (6 trials), "Anatomic Stage II Breast Cancer AJCC v8" (5 trials) and "Anatomic Stage III Breast Cancer AJCC v8" (5 trials). Many other conditions were trialed in "Minnesota Oncology - Burnsville" in a lesser frequency.

Most popular intervention types in "Minnesota Oncology - Burnsville" are "Drug" (87 trials), "Other" (61 trials), "Biological" (48 trials), "Procedure" (47 trials) and "Radiation" (17 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (36 trials), "Biospecimen Collection" (31 trials), "Questionnaire Administration" (31 trials), "Computed Tomography" (28 trials) and "Magnetic Resonance Imaging" (19 trials). Other intervention names were less common.

The vast majority of trials in "Minnesota Oncology - Burnsville" are 97 trials for "All" genders, 14 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Minnesota Oncology - Burnsville". undefined are not yet recruiting, 63 are recruiting, 37 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Minnesota Oncology - Burnsville, 5 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Minnesota Oncology - Burnsville, 0 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".